Scholar Rock, Inc.
Clinical trials sponsored by Scholar Rock, Inc., explained in plain language.
-
New drug aims to help people lose fat while keeping muscle
Disease control CompletedThis study tested whether adding an experimental drug called apitegromab to a standard weight loss medication (tirzepatide) could help overweight and obese adults lose weight more effectively. Researchers wanted to see if the combination could help people lose fat while preservin…
Phase: PHASE2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
Muscle-Boosting drug shows promise for children with rare neuromuscular disease
Disease control CompletedThis completed Phase 3 trial tested whether adding the experimental drug apitegromab to standard SMA treatments could improve muscle function in 188 children and young adults (ages 2-21) with later-onset spinal muscular atrophy. All participants were already receiving approved SM…
Phase: PHASE3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC